Novartis-Amgen’s Aimovig Poised for India Debut
Executive Summary
Novartis is planning to launch Aimovig in India after the migraine therapy was endorsed by an expert panel, but all eyes will be on pricing and how the company’s recent dispute with partner Amgen plays out.